Fox Business - The Power to Prosper
Search Site

Wednesday, April 7, 2010 as of 11:14 AM ET

Bill Weldon

J&J Chairman Weldon's Salary Cut To $1 Million After Stepping Down As CEO

Johnson & Johnson (JNJ) Chairman William Weldon's annual base salary was reduced by nearly half to $1 million after he stepped down as chief executive last month, the company said Monday.

Weldon's previous annual base salary was set at $1.97 million for 2012, for his roles as both chairman and CEO, but with the expectation that J&J's board would consider the appropriate compensation for Weldon in his role as chairman only.The decrease reflects that Weldon is no longer CEO, said spokesman Al Wasilewski.On April 26, Alex Gorsky succeeded Weldon as CEO. Weldon is continuing as chairman and will remain an employee of the company, J&J said in a quarterly report filed with the Securities and Exchange Commission Monday.J&J said in a previous SEC filing that in his role as chairman, Weldon will work closely with Gorsky to ensure a seamless leadership transition. During this time, all day-to-day management and operational responsibilities are being transferred to Gorsky.Weldon will remain an emp...

Read More

  1. Johnson & Johnson CEO to Step Down

    FBN’s Ashley Webster on Johnson & Johnson CEO William Weldon ’s plans to step down in April.

  2. New J&J CEO Lauded As Smart, Tested; Unlikely To Alter Strategy

    Johnson & Johnson's (JNJ) incoming CEO is viewed as having the experience and skills to lead the company out of a difficult period, but he's unlikely to change J&J's...

  3. WSJ BLOG/Health: J&J CEO Succession: Who is Alex Gorsky?

    (This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.)Johnson & Johnson will name Alex Gorsky as its next CEO, ...

  4. J&J CEO Weldon to Step Down, Vice Chair Gorsky to Step Up

    Johnson & Johnson (NYSE:JNJ) said late Tuesday that CEO William Weldon will retire late in April and be replaced by current vice chairman Alex Gorsky. Gorsky, 51, wi...

  5. WSJ BLOG/Health: J&J Still Sees Impact of McNeil Recalls, But Brands Are Coming Back

    (This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.)Johnson & Johnson avoided a third consecutive year of sal...

  6. J&J Beats Street Despite Hefty Charges, Forecast Disappoints

    Johnson & Johnson (NYSE:JNJ) reported a lower fourth-quarter profit related to one-time recall costs and its still-shuttered McNeil facility that hampered domestic o...

  7. J&J CEO:Annual Health Spending Growth In Midsingle Digits For Next 5 Yrs

    Johnson & Johnson (JNJ) Chief Executive William Weldon said Tuesday he expects annual global health-care spending growth in the midsingle digits on a percentage basi...

  8. Johnson & Johnson 4Q Profit Slumps 89% On Charges

    Johnson & Johnson (JNJ) reported an 89% drop in fourth-quarter profit due to legal settlements and product-liability costs, while the health-care giant avoided a thi...

  9. Most Overpaid CEOs

    It’s that time of year again, when proxies are released and many business publications run lists of the highest paid CEOs at America’s large public companies. The co...

  10. Johnson & Johnson Narrows 3Q Profit, But Beats Street

    Johnson & Johnson’s (NYSE:JNJ) third-quarter profit narrowed during the period on over-the-counter production disruptions that led to a decline in U.S. sales, howeve...

  11. J&J Quarterly Profit Slips on Settlements, Recalls

    Johnson & Johnson (NYSE:JNJ) revealed Tuesday a 20% decline in second-quarter profit that missed expectations, as strong international demand could not wholly offset...

  12. Fed Statement, Conference Boost Stocks

    FOX Business: The Power to ProsperThe markets rallied for a second-straight day after the Federal Reserve said it plans on keeping short-term interest rates at extra...

  1. J&J New CEO: Top Job Is Fixing Over-The-Counter Drug Business

    NEW BRUNSWICK, N.J. -(Dow Jones)- Alex Gorsky, Johnson & Johnson's (JNJ) incoming chief executive, said his No. 1 priority was fixing the problems in the company's o...

  2. J&J 1Q Profit Up 12.5% On Forex Gain, Sales Down Slightly

    Johnson & Johnson (JNJ) Tuesday reported a slight decline in first-quarter sales because of drug patent expirations and manufacturing constraints, but the company po...

  3. US Wants To Question Incoming J&J CEO In Kickback Lawsuit

    The U.S. Department of Justice has asked a federal judge to compel incoming Johnson & Johnson (JNJ) Chief Executive Alex Gorsky to undergo questioning as part of a l...

  4. Pfizer CEO Pay Jumps on Turnaround Efforts

    Pfizer Inc (NYSE:PFE) said Chief Executive Ian Read's compensation jumped more than 40 percent last year to $25 million as he steered a steady course for the world's...

  5. J&J CEO Weldon Retirement Pay Sseen at $143.5M

    Johnson & Johnson's (NYSE:JNJ) outgoing CEO William Weldon could receive more than $140 million when he leaves the company, according to a regulatory filing on Wedne...

  6. J&J CEO Weldon's Retirement Benefits Valued At $143.5 Million

    Johnson & Johnson (JNJ) Chairman and Chief Executive William Weldon stands to collect pension and deferred compensation currently valued at $143.5 million after his ...

  7. J&J CEO Weldon Gets 55% Increase In Performance Bonus For 2011

    Johnson & Johnson's (JNJ) outgoing chief executive has received a 55% increase in his annual performance bonus for 2011, partially restoring the cut he was dealt for...

‹ Prev12Next ›
Freebase CC-BY
Source: Bill Weldon on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL